| abstract |
The present invention relates to a humanized antibody or fragment thereof that binds to human CD19. More specifically, the present invention provides a heavy chain CDR1 having the amino acid sequence of SEQ ID NO: 27 and / or a heavy chain CDR2 having the amino acid sequence of SEQ ID NO: 28 and / or a heavy chain CDR3 having the amino acid sequence of SEQ ID NO: 29; And / or binds to human CD19 having light chain CDR1 having the amino acid sequence of SEQ ID NO: 30 and / or light chain CDR2 having the amino acid sequence of SEQ ID NO: 31 and / or light chain CDR3 having the amino acid sequence of SEQ ID NO: 32 It relates to a humanized antibody or fragment thereof. [Selection figure] None |